ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen
ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...
TMCnet20h
Know Labs Announces Approval to Begin Trading on the OTCQB Market
The OTCQB is recognized as an "established public market" by the U.S. Securities and Exchange Commission and is a leading market for U.S. and international companies in the entrepreneurial and ...
Swedish Orphan Biovitrum AB: US FDA grants Priority Review to Sobi's supplemental Biologics Licence Application (sBLA) for Gamifant (emapalumab-lzsg)
Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) ...
ADB Consulting & CRO Inc: Natural Dior LLC Issues Voluntary Nationwide Recall of Vitafer-L Gold Liquid Due to Presence of Undeclared Tadala?l
MIAMI, FLORIDA / ACCESS Newswire / February 26, 2025 / Natural Dior LLC, is voluntarily recalling the affected lots of ...
Google Pixel Watch 3 just got FDA approval for pulse detection feature — here's when it's coming
The Google Pixel Watch 3 hit the market last year, but a significant feature was missing from the watch in the U.S.: loss of pulse detection. The feature needed to get approval from the Food and Drug ...
Antiaging pill for dogs clears key FDA hurdle
The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...
Hosted on MSN1d
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin ...
pulmonologyadvisor1d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The US FDA has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes.
uniQure N.V.: A Potential Huntington's Play
Qure's stock rises on Huntington's therapy progress and strong gene therapy pipeline. Learn about QURE stock's cost-cutting ...
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will ...
JD Supra3d
FDA Accepts U.S. Biologics License Application for AVT06, Alvotech and Teva’s Proposed Aflibercept Biosimilar
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
GEN4d
StockWatch: Bluebird Bio Plunges on Buyout, as Gene Therapy’s Woes Grow
Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...